Logotype for Primary Health Properties PLC

Primary Health Properties (PHP) H2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Primary Health Properties PLC

H2 2025 earnings summary

25 Mar, 2026

Executive summary

  • Completed transformational merger with Assura PLC, creating the UK's largest healthcare REIT with a £6bn portfolio and 1,142 assets, doubling portfolio size and enhancing strategic capabilities.

  • Achieved 4% growth in adjusted earnings per share and marked the 30th consecutive year of dividend growth, with strong financial and operational performance.

  • Integration of the merged businesses is ahead of schedule, with over £7.5m of £9m cost synergies already delivered.

  • Portfolio remains resilient with 99% occupancy, 11-year WAULT, and 76% government-backed income.

  • Strategic focus on deleveraging through joint ventures and asset transfers, with strong progress reported.

Financial highlights

  • Adjusted earnings per share increased by 4% year-over-year to 7.3p; adjusted earnings up 41% to £131m.

  • Gross annual passing rent roll increased 122% to £342m; net rental income up 49% to £230m.

  • Portfolio revaluation gain of £48m, reversing a £38m deficit in the prior year, driven by rental growth.

  • EPRA NTA per share at 99p, down 4% due to one-off merger costs; adjusted NTA at 104p.

  • Dividend per share up 3% to 7.1p, marking 30 years of consecutive growth and an 8% CAGR.

Outlook and guidance

  • Confident in delivering full £9m synergy target in H1 2026, with full-year earnings impact in FY27.

  • Targeting leverage reduction to below 50% LTV and net debt-to-EBITDA below 9.5x.

  • Expecting continued organic rental growth above 3% and strong sector tailwinds.

  • Positioned to support UK Government’s 10-year health plan and NHS infrastructure investment.

  • Integration synergies and development pipeline expected to drive future earnings.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more